Elgar Middleton Bio Power Limited Filleted Accounts Cover
Elgar Middleton Bio Power Limited
Company No. 09426501
Information for Filing with The Registrar
31 March 2023
Elgar Middleton Bio Power Limited Directors Report Registrar
The Directors present their report and the accounts for the year ended 31 March 2023.
Principal activities
The principal activity of the company during the year under review was development of anaerobic digestion facilities for the generation of electricity and biomethane.
Directors
The Directors who served at any time during the year were as follows:
E.B. Elgar
S.R. Middleton
J.W.D. Wallwork
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
E.B. Elgar
Director
16 November 2023
Elgar Middleton Bio Power Limited Balance Sheet Registrar
at
31 March 2023
Company No.
09426501
Notes
2023
2022
£
£
Fixed assets
Investments
4
12,42112,421
12,42112,421
Current assets
Debtors
5
116,667116,667
Cash at bank and in hand
2,2903,762
118,957120,429
Creditors: Amount falling due within one year
6
(279,000)
(279,000)
Net current liabilities
(160,043)
(158,571)
Total assets less current liabilities
(147,622)
(146,150)
Net liabilities
(147,622)
(146,150)
Capital and reserves
Called up share capital
1212
Profit and loss account
8
(147,634)
(146,162)
Total equity
(147,622)
(146,150)
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 16 November 2023 and signed on its behalf by:
E.B. Elgar
Director
16 November 2023
Elgar Middleton Bio Power Limited Notes to the Accounts Registrar
for the year ended 31 March 2023
1
General information
Elgar Middleton Bio Power Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 09426501
Its registered office is:
1 Lancaster Place
London
WC2E 7ED
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Investments
Unlisted investments (except those held as subsidiaries, associates or joint ventures) are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, any changes in fair value are recognised in profit and loss.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the balance sheet.
3
Employees
2023
2022
Number
Number
The average monthly number of employees (including directors) during the year was:
00
4
Investments
Investment in Subsidiaries
Total
£
£
Cost or valuation
At 1 April 2022
12,421
12,421
At 31 March 2023
12,421
12,421
Provisions/Impairment
Net book values
At 31 March 2023
12,421
12,421
At 31 March 2022
12,421
12,421
5
Debtors
2023
2022
£
£
Amounts owed by group undertakings
116,667116,667
116,667116,667
6
Creditors:
amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings
279,000
279,000
279,000279,000
7
Share Capital
Ordinary shares
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
Elgar Middleton Bio Power Limited0942650131 March 202301 April 2022false16 November 2023BTCSoftware AP Solution 2023 10.4.0410.4.04true094265012022-04-012023-03-31094265012023-03-31094265012022-03-3109426501core:WithinOneYear2023-03-3109426501core:WithinOneYear2022-03-3109426501core:ShareCapital2023-03-3109426501core:ShareCapital2022-03-3109426501core:RetainedEarningsAccumulatedLosses2023-03-3109426501core:RetainedEarningsAccumulatedLosses2022-03-3109426501countries:UnitedKingdom2022-04-012023-03-3109426501bus:RegisteredOffice2022-04-012023-03-31094265012021-04-012022-03-3109426501core:CostValuation2022-04-0109426501core:CostValuation2023-03-3109426501core:CostValuationcore:UnlistedNon-exchangeTraded2023-03-3109426501core:RetainedEarningsAccumulatedLosses2022-04-012023-03-31094265012022-04-0109426501bus:SmallEntities2022-04-012023-03-3109426501bus:FullAccounts2022-04-012023-03-3109426501bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3109426501bus:Director12022-04-012023-03-3109426501bus:PrivateLimitedCompanyLtd2022-04-012023-03-31iso4217:GBPxbrli:pure